Monthly information on share capital and company voting rights

Rhea-AI Summary

In a recent press release, Cellectis provided information on their share capital and company voting rights for April 30, 2024. The total number of shares in the capital was reported as 71,955,535 with a total number of voting rights at 77,891,229. This data was disclosed in compliance with Article 223-16 of the General Regulation of the French financial markets authority.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, May 06, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
04/30/2024	71,955,535	77,891,229

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com  

Investor Relations contacts:       

Arthur Stril, Chief Financial Officer (interim), +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577  

 

Attachment

• Voting_Rights_PR_April_2024_EN_

FAQ

What is the total number of shares in the capital for Cellectis as of April 30, 2024?

The total number of shares in the capital for Cellectis as of April 30, 2024, was reported to be 71,955,535.

How many voting rights does Cellectis have as of April 30, 2024?

Cellectis had a total of 77,891,229 voting rights as of April 30, 2024.

What is the ISIN code for Cellectis?

The ISIN code for Cellectis is FR0010425595.

What is the date of the report on share capital and voting rights provided by Cellectis?

The report on share capital and voting rights was provided by Cellectis on April 30, 2024.

Who can be contacted for media inquiries regarding Cellectis?

For media inquiries regarding Cellectis, you can contact Pascalyne Wilson, Director of Communications, at +33 (0)7 76 99 14 33 or Patricia Sosa Navarro, Chief of Staff to the CEO, at +33 (0)7 76 77 46 93.

Who are the Investor Relations contacts for Cellectis?

The Investor Relations contacts for Cellectis are Arthur Stril, the Chief Financial Officer (interim), at +1 (347) 809 5980 and Ashley R. Robinson from LifeSci Advisors at +1 617 430 7577.